Pharmaceutical Business review

Nilodor Inks Deal With BioTech Medical For SpectraSan 24

Nilodor, is expected to distribute SpectraSan 24 to more than 1800 sales and distribution partners around the country.

BioTech Medical claimed that unlike traditional alcohol or bleach-based surface disinfectants, SpectraSan 24 requires no hazard or warning statements and boasts bacterial kill times as quick as 30 seconds, compared with 10 minutes for competing products due to its SDC technology.

Additionally, SpectraSan 24 provides protection even against Norovirus, Influenza A (H1N1), SARS, HIV and antibiotic resistant pathogens such as MRSA, CA-MRSA, and VRE. It continues to kill bacteria for up to 24 hours after usage and yet holds the EPA’s Category IV toxicity rating, the lowest classification available. Furthermore, SpectraSan 24 is specifically labeled for use in sensitive childcare environments.

Andrea Goren, executive director of BioTech Medical, said: “We are well-positioned to supply a much needed preventative solution to the ‘silent threats’ of disease causing pathogens that lurk on frequently touched hard surfaces in the home, at work, and within the community. Nilodor’s vast network of sales and distribution channels provides us with the national and international reach that our product demands.”